BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+15.53%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.52B
AUM Growth
+$1.52B
(+21%)
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
6.2%
Top 10 Holdings %
Top 10 Hldgs %
46.09%
Holding
98
New
17
Increased
26
Reduced
19
Closed
7
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$22.6M |
| 2 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$20.8M |
| 3 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
$17.2M |
| 4 |
Zevra Therapeutics
ZVRA
|
$15.2M |
| 5 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$13.9M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$77.7M |
| 2 |
Travere Therapeutics
TVTX
|
$26.5M |
| 3 |
Heron Therapeutics
HRTX
|
$12.8M |
| 4 |
Amphastar Pharmaceuticals
AMPH
|
$12.5M |
| 5 |
UAM
Universal American Corp
UAM
|
$12.1M |
Sector Composition
| 1 | Healthcare | 92.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Verastem
VSTM
$585M
| $7.92M | 0.43% |
1,050,000
| – | – |
|
|
FLXN
52
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $7.62M | 0.41% |
348,204
| – | – |
|
53
Tenax Therapeutics
TENX
$27.5M
| $7.26M | 0.39% |
1,968,631
| – | – |
|
|
GNMX
54
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $6.83M | 0.37% |
1,113,900
+88,900
| +9% | +$545K |
|
55
Tonix Pharmaceuticals
TNXP
$243M
| $6.82M | 0.37% |
760,748
-415,891
| -35% | -$7.44M |
|
56
SCYNEXIS
SCYX
$35.2M
| $6.81M | 0.37% |
+775,000
| New | +$6.81M |
|
|
RDHL
57
Redhill Biopharma
RDHL
$2.94M
| $6.77M | 0.36% |
384,281
-100,000
| -21% | -$1.76M |
|
58
Accuray
ARAY
$165M
| $6.74M | 0.36% |
1,000,000
+300,000
| +43% | +$2.02M |
|
|
ABMD
59
DELISTED
Abiomed Inc
ABMD
| $6.57M | 0.35% |
+100,000
| New | +$6.57M |
|
|
CASC
60
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $6.36M | 0.34% |
1,700,000
-1,800,000
| -51% | -$6.73M |
|
|
NVDQ
61
DELISTED
Novadaq Technologies Inc.
NVDQ
| $6.34M | 0.34% |
523,863
+200,000
| +62% | +$2.42M |
|
|
EGLT
62
DELISTED
Egalet Corporation
EGLT
| $6.27M | 0.34% |
+434,750
| New | +$6.27M |
|
|
PLXP
63
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $6.04M | 0.32% |
475,000
| – | – |
|
|
CFRX
64
DELISTED
ContraFect Corporation
CFRX
| $5.96M | 0.32% |
+1,418,440
| New | +$5.96M |
|
65
Xoma
XOMA
$421M
| $5.82M | 0.31% |
1,500,000
| – | – |
|
|
ALBO
66
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $5.75M | 0.31% |
5,580,034
+4,250,000
| +320% | +$4.38M |
|
|
VXRT
67
DELISTED
Vaxart
VXRT
| $5.41M | 0.29% |
2,611,711
| – | – |
|
|
WINT
68
DELISTED
Windtree Therapeutics Inc
WINT
| $5.32M | 0.29% |
7,822,500
-250,000
| -3% | -$170K |
|
69
Collegium Pharmaceutical
COLL
$1.25B
| $5.3M | 0.28% |
+297,200
| New | +$5.3M |
|
70
DURECT Corp
DRRX
$60.2M
| $5.25M | 0.28% |
2,195,378
-1,709,117
| -44% | -$4.08M |
|
|
NBSE
71
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $4.46M | 0.24% |
1,775,000
| – | – |
|
|
CRDC
72
DELISTED
CARDICA INC COM NEW (DE)
CRDC
| $4.43M | 0.24% |
8,874,992
| – | – |
|
|
EPRS
73
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $4.43M | 0.24% |
775,000
| – | – |
|
74
OraSure Technologies
OSUR
$230M
| $3.7M | 0.2% |
685,528
+635,528
| +1,271% | +$3.43M |
|
75
Neurogene
NGNE
$284M
| $3.69M | 0.2% |
531,768
| – | – |
|